Most clinical research institutions believe their study start-up delays are a technology problem. They aren’t. It’s a fragmentation problem, and many technologies have only made it worse. This article examines how AI-enabled digitisation creates a single authoritative source from protocol through activation, what that means for the over a dozen internal groups who depend on that information and why speed and congruency together, not either alone, are the real prize.


